Paid sick leave during 52 week follow‐up
| | | | |
Number (percentage) on leave
|
30 (52)
|
31 (56)
|
30 (55)
|
0.88
|
Duration of leave for those on sick‐leave:
| | | | |
Days on full leave mean (95 % CI)
|
43.6 (22.0 to 65.1)
|
73.2 (34.2 to 112.2)
|
47.1 (30.0 to 64.3)
|
0.25*
|
Days on partial leave mean (95 % CI)
|
60.0 (23.1 to 96.9)
|
22.0 (6.8 to 37.3)
|
29.2 (11.2 to 47.2)
|
0.07*
|
Additional treatments
| | | | |
Number of patients receiving additional treatments
|
13 (23)
|
12 (22)
|
16 (30)
|
0.63
|
Type of treatment:
| | | | |
Pain killers
|
6 (11)
|
4 (7)
|
2 (4)
|
0.37
|
NSAIDs perorally
|
7 (13)
|
9 (16)
|
11 (20)
|
0.54
|
topical NSAIDs
|
3 (5)
|
1 (2)
|
2 (4)
|
0.62
|
other medication
|
3 (6)
|
0 (0)
|
3 (6)
|
0.22
|
physiotherapy
|
4 (7)
|
1 (2)
|
9 (17)
|
0.02+
|
other
|
6 (11)
|
4 (7)
|
4 (8)
|
0.76
|
Adverse Events
| | | | |
Patients reporting adverse events
|
9 (16)
|
5 (9)
|
6 (11)
|
0.51
|
Type of adverse events
| | | | |
increased pain
|
2 (4)
|
2 (4)
|
0 (0)
|
0.37
|
GI side effects**
|
8 (15)
|
3 (6)
|
6 (11)
|
0.30
|
skin atrophy
|
0 (0)
|
0 (0)
|
0 (0)
|
‐
|